TSG101 and invasive breast carcinoma: Using immunohistochemistry on formalin-fixed sections of 16 human breast cancers and 16 normal breast tissues and benign hyperplasia, we found that the levels of TSG101 were significantly higher in approximately half of the invasive breast cancer cases [20].